REQUEST A DEMO
Total
USD $0.00
Search more companies

Gled C Pharma Sas (Colombia)

Main Activities: Pharmacies and Drug Stores
Full name: Gled C Pharma Sas Profile Updated: June 03, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2021 Available in: English & Spanish Download a sample report

Gled C Pharma Sas is an enterprise located in Colombia, with the main office in Cota. It operates in the Pharmacies and Drug Stores industry. The company was established on July 10, 2009. It currently has a total number of 1 (2020) employees. The company’s latest financial report indicates a net sales revenue drop of 38.91% in 2021. A growth of 0.18% was recorded in its total assets. In, 2021, the company’s net profit margin increased by 1.31%.

Headquarters
Via Autop.Medellin K
Cota; Cundinamarca;

Contact Details: Purchase the Gled C Pharma Sas report to view the information.

Basic Information
Total Employees:
Purchase the Gled C Pharma Sas report to view the information.
Outstanding Shares:
Purchase the Gled C Pharma Sas report to view the information.
Incorporation Date:
July 10, 2009
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Alternate Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Gled C Pharma Sas report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-38.91%
Total operating revenue
-38.91%
Operating profit (EBIT)
1.64%
Net Profit (Loss) for the Period
-9.71%
Total assets
0.18%
Total equity
2.14%
Operating Profit Margin (ROS)
3.02%
Net Profit Margin
1.31%
Return on Equity (ROE)
-0.27%
Quick Ratio
0.31%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?